Your browser doesn't support javascript.
loading
Long-Term Benefits from Early Antiretroviral Therapy Initiation in HIV Infection.
Lundgren, Jens D; Babiker, Abdel G; Sharma, Shweta; Grund, Birgit; Phillips, Andrew N; Matthews, Gail; Kan, Virginia L; Aagaard, Bitten; Abo, Inka; Alston, Beverly; Arenas-Pinto, Alejandro; Avihingsanon, Anchalee; Badal-Faesen, Sharlaa; Brites, Carlos; Carey, Cate; Casseb, Jorge; Clarke, Amanda; Collins, Simon; Corbelli, Giulio Maria; Dao, Sounkalo; Denning, Eileen T; Emery, Sean; Eriobu, Nnakelu; Florence, Eric; Furrer, Hansjakob; Fätkenheuer, Gerd; Gerstoft, Jan; Gisslén, Magnus; Goodall, Katharine; Henry, Keith; Horban, Andrzej; Hoy, Jennifer; Hudson, Fleur; Azwa, Raja Iskandar Shah Raja; Kedem, Eynat; Kelleher, Anthony; Kityo, Cissy; Klingman, Karin; Rosa, Alberto La; Leturque, Nicolas; Lifson, Alan R; Losso, Marcelo; Lutaakome, Joseph; Madero, Juan Sierra; Mallon, Patrick; Mansinho, Kamal; Filali, Kamal Marhoum El; Molina, Jean-Michel; Murray, Daniel D; Nagalingeswaran, Kumarasamy.
Afiliação
  • Lundgren JD; CHIP Centre of Excellence for Health, Immunity, and Infections, Department of Infectious Diseases, Rigshospitalet, Copenhagen.
  • Babiker AG; Medical Research Council Clinical Trials Unit, University College London, London.
  • Sharma S; Division of Biostatistics, School of Public Health, University of Minnesota, Minneapolis.
  • Grund B; School of Statistics, University of Minnesota, Minneapolis.
  • Phillips AN; Institute for Global Health, University College London, London.
  • Matthews G; Kirby Institute, Sydney.
  • Kan VL; VA Medical Center, Washington, D.C.
  • Aagaard B; CHIP Centre of Excellence for Health, Immunity, and Infections, Department of Infectious Diseases, Rigshospitalet, Copenhagen.
  • Abo I; Helsinki University Central Hospital, Helsinki.
  • Alston B; Division of AIDS, National Institute of Allergy and Infectious Diseases, Bethesda, MD.
  • Arenas-Pinto A; Medical Research Council Clinical Trials Unit, University College London, London.
  • Avihingsanon A; Thai Red Cross AIDS Research Centre, Bangkok, Thailand.
  • Badal-Faesen S; Clinical HIV Research Unit, Department of Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg.
  • Brites C; Hospital Universitario Professor Edgard Santos, School of Medicine, Federal University of Bahia, Salvador, Brazil.
  • Carey C; Kirby Institute, Sydney.
  • Casseb J; Laboratory of Medical Investigation - LIM56, Faculty of Medicine, Department of Dermatology, University of São Paulo, São Paulo.
  • Clarke A; Royal Sussex County Hospital, Brighton, United Kingdom.
  • Collins S; HIV i-Base, London.
  • Corbelli GM; European AIDS Treatment Group, Brussels.
  • Dao S; Mali-National Institute of Allergy and Infectious Diseases HIV Research Initiative, Bamako, Mali.
  • Denning ET; Division of Biostatistics, School of Public Health, University of Minnesota, Minneapolis.
  • Emery S; UNSW Medicine, Sydney.
  • Eriobu N; Institute of Human Virology Nigeria, Abuja, Nigeria.
  • Florence E; Institute of Tropical Medicine, Antwerp, Belgium.
  • Furrer H; Department of Infectious Diseases, Bern University Hospital, University of Bern, Bern, Switzerland.
  • Fätkenheuer G; Klinik I für Innere Medizin der Universität zu Köln, Cologne, Germany.
  • Gerstoft J; Rigshospitalet, Infektionsmedicinsk ambulatorium 8622, Copenhagen.
  • Gisslén M; Sahlgrenska University Hospital, Gothenburg, Sweden.
  • Goodall K; Medical Research Council Clinical Trials Unit, University College London, London.
  • Henry K; Hennepin Health Research Institute, Minneapolis.
  • Horban A; Wojewódzki Szpital Zakazny, Warsaw, Poland.
  • Hoy J; Department of Infectious Diseases, The Alfred Hospital and Monash University, Melbourne, VIC, Australia.
  • Hudson F; Medical Research Council Clinical Trials Unit, University College London, London.
  • Azwa RISR; University Malaya Medical Centre, Kuala Lumpur, Malaysia.
  • Kedem E; Rambam Medical Center, Haifa, Israel.
  • Kelleher A; Kirby Institute, Sydney.
  • Kityo C; Joint Clinical Research Centre, Kampala, Uganda.
  • Klingman K; Division of AIDS, National Institute of Allergy and Infectious Diseases, Bethesda, MD.
  • Rosa A; Asociación Civil IMPACTA Salud y Educación, Lima, Peru.
  • Leturque N; INSERM SC10-US19, Villejuif, Paris.
  • Lifson AR; University of Minnesota, Minneapolis.
  • Losso M; Hospital General de Agudos J.M. Ramos Mejia, Buenos Aires.
  • Lutaakome J; MRC/UVRI and LSHTM Uganda Research Unit, Entebbe, Uganda.
  • Madero JS; Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City.
  • Mallon P; Centre for Experimental Pathogen Host Research, University College Dublin, Dublin.
  • Mansinho K; Hospital de Egas Moniz, Lisbon, Portugal.
  • Filali KME; University Hospital Centre Ibn Rochd, Casablanca, Morocco.
  • Molina JM; Hôpital Saint-Louis, Paris.
  • Murray DD; CHIP Centre of Excellence for Health, Immunity, and Infections, Department of Infectious Diseases, Rigshospitalet, Copenhagen.
  • Nagalingeswaran K; Voluntary Health Services, Infectious Diseases Medical Centre, Chennai Antiviral Research and Treatment, Clinical Research Site, Chennai, India.
NEJM Evid ; 2(3)2023 Mar.
Article em En | MEDLINE | ID: mdl-37213438

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Revista: NEJM Evid Ano de publicação: 2023 Tipo de documento: Article País de publicação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Revista: NEJM Evid Ano de publicação: 2023 Tipo de documento: Article País de publicação: Estados Unidos